Literature DB >> 30756074

Not All Strokes Are Strokes An Example of Diagnostic Confirmation Bias.

Melanie Dani1, Sophie Bowen-Carpenter1, Patrick J McGown1.   

Abstract

A 72-year-old woman presented with a complex partial seizure and right hemiparesis, after a four-week history of cognitive decline, apraxia and speech disturbance. She previously had chronic lymphocytic leukaemia (CLL) and had finished chemotherapy one year prior to presentation. She was receiving monthly intravenous immunoglobulins for bronchiectasis. Brain imaging showed hypodensity in the left temporo-parietal regions. Cerebrospinal fluid was positive for the JC virus, leading to a diagnosis of progressive multifocal leucoencephalopathy (PML). She remains alive, eight months following initial presentation. The case was valuable for reflective practice in avoiding diagnostic (confirmation) bias because the treating team pursued an incorrect diagnosis of stroke and secondary seizure after radiology findings appeared consistent with this. Additionally, PML has not previously been reported in individuals with CLL receiving immunoglobulin therapy, and may explain the relatively benign course in this individual patient. This offers a potential research question for disease modifying treatments in PML. LEARNING POINTS: This case highlights new insights into an uncommon but important condition: always consider progressive multifocal leucoencephalopathy when immunocompromised patients present with neurological symptoms.A full differential diagnosis should always be considered, even in the context of a more 'plausible' diagnosis.Avoid premature closure and confirmation bias as cognitive errors in diagnostic reasoning.

Entities:  

Keywords:  Chronic lymphocytic leukaemia; immunocompromised; progressive multifocal leucoencephalopathy

Year:  2019        PMID: 30756074      PMCID: PMC6372046          DOI: 10.12890/2019_001006

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  7 in total

Review 1.  Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned.

Authors:  Eugene O Major; Tarek A Yousry; David B Clifford
Journal:  Lancet Neurol       Date:  2018-05       Impact factor: 44.182

Review 2.  Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia: a report of three cases and review of the literature.

Authors:  Anita D'Souza; Jon Wilson; Sudipto Mukherjee; Ishmael Jaiyesimi
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2010-02

Review 3.  Persistence and pathogenesis of the neurotropic polyomavirus JC.

Authors:  Hassen S Wollebo; Martyn K White; Jennifer Gordon; Joseph R Berger; Kamel Khalili
Journal:  Ann Neurol       Date:  2015-03-06       Impact factor: 10.422

4.  Progressive multifocal leukoencephalopathy and hematologic malignancies: a single cancer center retrospective review.

Authors:  Elizabeth C Neil; Lisa M DeAngelis
Journal:  Blood Adv       Date:  2017-10-18

5.  Progressive multifocal leukoencephalopathy complicating untreated chronic lymphatic leukemia: case report and review of the literature.

Authors:  Franziska Di Pauli; Thomas Berger; Alois Walder; Hans Maier; Paul Rhomberg; Christian Uprimny; Michael Steurer; Guenther Stockhammer
Journal:  J Clin Virol       Date:  2014-05-22       Impact factor: 3.168

6.  Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab.

Authors:  Z Calic; C Cappelen-Smith; S J Hodgkinson; A McDougall; R Cuganesan; B J Brew
Journal:  J Clin Neurosci       Date:  2014-12-15       Impact factor: 1.961

Review 7.  Progressive Multifocal Leukoencephalopathy.

Authors:  Laura Adang; Joseph Berger
Journal:  F1000Res       Date:  2015-12-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.